GlassScriptPhysician profile
Robin Ifeoma Iriele
NPI 1730610676
$1,129.57
in general payments reported to CMS, 2019-2025
24 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.55 · 2021: $122 · 2022: $123 · 2023: $302 · 2024: $279 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $136.23 | 2023-2024 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $125.88 | 2022-2025 | Erleada, Balversa, Akeega |
| Endo Pharmaceuticals INC. | $121.64 | 2021 | |
| Calyxo, INC. | $70.13 | 2024-2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $62.13 | 2023-2025 | Jelmyto |
| Axonics, INC. | $60.87 | 2023-2024 | Axonics, Bulkamid |
| Teleflex LLC | $49.17 | 2022 | |
| Coloplast Corp | $47.50 | 2023-2024 | Speedicath |
| Progenics Pharmaceuticals, INC. | $44.57 | 2023-2024 | Pylarify |
| Astellas Pharma US INC | $42.59 | 2022-2024 | Myrbetriq |
| Laborie Medical Technologies Corp. | $40.62 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Vertex Pharmaceuticals Incorporated | $39.55 | 2025 | |
| Boston Scientific Corporation | $37.55 | 2019-2023 | |
| Blue Earth Diagnostics | $36.85 | 2025 | Posluma |
| Ambu INC. | $34.83 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $27.31 | 2022-2024 | |
| Endo USA, INC. | $25.49 | 2025 | Xiaflex |
| Curium US LLC | $24.71 | 2023 | |
| Axogen | $19.91 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $19.21 | 2025 | Personal Catheter Intermittent Catheter |
| Myriad Genetic Laboratories, INC. | $18.61 | 2023 | Prolaris |
| Accord Healthcare, INC. | $16.69 | 2023 | |
| Janssen Scientific Affairs, LLC | $14.25 | 2023 | Pipeline, Akeega, Erleada |
| Urovant Sciences INC | $13.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Iriele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.